TABLE 1.
Integrity ID | IUPAC Name | Structural Formula | Molecular Mechanism | Therapeutic Group |
---|---|---|---|---|
HYP-1 | 2,4-Bis(3-methylbutyryl)phloroglucinol 2,4-bis(3-methylbutyryl)-1,3,5-trihydroxybenzene | 1) TRPC6 agonists; 2) leukotriene CysLT1 (LTD4) antagonists; 3) antagonists free fatty acid receptor 1 (FFAR1; PR40); 4) agonists signal transduction modulators; 5) prostanoid thromboxane receptors antagonists; and 6) leukotriene antagonists | 1) Antiallergy/antiasthmatic drugs; 2) antiviral; and 3) agents for type 2 diabetes | |
HYP-5 | 1,1′-(2,4,6-Trihydroxybenzene-1,3-diyl)bis(4-methylpentan-1-one) | 1) TRPC6 Agonists | 1) Treatment of cognition disorders | |
HYP-9 | 1,1′-(2,4,6-Trihydroxybenzene-1,3-diyl)dihexan-1-one | 1) TRPC6 Agonists | 1) Treatment of cognition disorders | |
830288 | [4-(5-Chloro-2-methylphenyl)piperazin-1-yl](3-fluorophenyl)methanone | 1) TRPC6 Agonists | 1) Psychiatric disorders (not specified); and 2) treatment of neurodegenerative diseases | |
871099 | N-(2-Chlorophenyl)-2-[4-(2,3-dimethylphenyl)piperazin-1-yl]acetamide trifluoroacetate | 1) TRPC6 agonists; and 2) TRPC3 agonists | 1) Psychiatric disorders (not specified); and 2) treatment of neurodegenerative diseases | |
880395 | 2-[4-(2,3-Dimethylphenyl)piperazin- 1-yl]-N-(2-fluorophenyl)acetamide trifluoroacetate | 1) TRPC6 agonists; and 2) TRPC3 agonists | 1) Psychiatric disorders (not specified); and 2) treatment of neurodegenerative diseases |
ID, identification; IUPAC, International Union of Pure and Applied Chemistry.